Japan Radiotherapy Market Report by Type, Application, End User, and Region 2024-2032

Description

Japan radiotherapy market size is projected to exhibit a growth rate (CAGR) of 7.98% during 2024-2032. The inflating healthcare expenditure capacities, along with the growing need for effective treatment methods that relieve symptoms of advanced cancers, are primarily driving the market growth.

Radiotherapy, alternatively referred to as radiation therapy, serves the purpose of retarding the proliferation of cancer cells and reducing the size of tumors. This treatment modality disrupts the genetic material within cancer cells through the utilization of high-energy particles or waves, encompassing options like x-rays, gamma rays, electron beams, or protons. In many cases, it is employed in conjunction with other cancer therapies such as surgery, chemotherapy, and immunotherapy to enhance their efficacy. In line with this, the decision to administer radiotherapy to patients hinges on factors such as the specific cancer type, the tumor's dimensions and location, the patient's medical history, age, and overall health conditions. Consequently, it is used in hospitals across Japan.

Japan Radiotherapy Market Trends:

The increasing incidence of cancer due to unhealthy dietary habits, insufficient physical activity, rising air pollution levels, and the growing consumption of alcohol and tobacco constitutes a major factor driving market growth in Japan. Furthermore, the risk of cancer development significantly escalates with age, as cellular repair mechanisms become less effective in older individuals. Consequently, the increasing elderly population in Japan is acting as another substantial catalyst for market expansion. Additionally, the advancement of cost-effective, user-friendly radiotherapy products is further augmenting market growth. Furthermore, modern radiotherapy techniques like three-dimensional (3D) conformal, intensity-modulated, and image-guided approaches deliver a higher radiation dose to tumors while minimizing exposure to healthy tissues, enhancing the protection of critical organs, and providing patients with a painless experience, which is acting as another significant growth-inducing factor. These techniques are gaining traction across various applications and healthcare settings for the treatment of chronic diseases, consequently driving global demand for radiotherapy. Moreover, the market is poised for growth due to the escalating healthcare expenditure in both developed and emerging economies within Japan. All these factors are expected to propel the regional market in the coming years.

Japan Radiotherapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type, application, and end user.

Type Insights:

External Beam Radiation Therapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
- Tomotherapy
- Stereotactic Radiosurgery
- Stereotactic Body Radiation Therapy
- Proton Therapy
- 3D Conformal Radiotherapy (3D CRT)
- Volumetric Modulated Arc Therapy (VMAT)
Internal Radiation Therapy/Brachytherapy
Systemic Radiation Therapy

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, 3D conformal radiotherapy (3D CRT), and volumetric modulated arc therapy (VMAT)), internal radiation therapy/brachytherapy, and systemic radiation therapy.

Application Insights:

Skin and Lip Cancer
Head and Neck Cancer
Breast Cancer
Prostate Cancer
Cervical Cancer
Lung Cancer
Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others.

End User Insights:

Hospitals
Cancer Research Institutes
Ambulatory and Radiotherapy Centers

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers.

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

Elekta K.K. (Elekta)
Hitachi Ltd.
Osaka Heavy Ion Therapy Center
Sumitomo Heavy Industries Ltd.
Toshiba Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key Questions Answered in This Report:

How has the Japan radiotherapy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan radiotherapy market?
What is the breakup of the Japan radiotherapy market on the basis of type?
What is the breakup of the Japan radiotherapy market on the basis of application?
What is the breakup of the Japan radiotherapy market on the basis of end user?
What are the various stages in the value chain of the Japan radiotherapy market?
What are the key driving factors and challenges in the Japan radiotherapy?
What is the structure of the Japan radiotherapy market and who are the key players?
What is the degree of competition in the Japan radiotherapy market?

Product Code: SR112024A18341

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Radiotherapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Radiotherapy Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Radiotherapy Market - Breakup by Type

6.1 External Beam Radiation Therapy
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Intensity-Modulated Radiation Therapy (IMRT)
  - 6.1.3.2 Image-Guided Radiation Therapy (IGRT)
  - 6.1.3.3 Tomotherapy
  - 6.1.3.4 Stereotactic Radiosurgery
  - 6.1.3.5 Stereotactic Body Radiation Therapy
  - 6.1.3.6 Proton Therapy
  - 6.1.3.7 3D Conformal Radiotherapy (3D CRT)
  - 6.1.3.8 Volumetric Modulated Arc Therapy (VMAT)
- 6.1.4 Market Forecast (2024-2032)
6.2 Internal Radiation Therapy/Brachytherapy
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
6.3 Systemic Radiation Therapy
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)

7 Japan Radiotherapy Market - Breakup by Application

7.1 Skin and Lip Cancer
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 Head and Neck Cancer
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)
7.3 Breast Cancer
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2018-2023)
- 7.3.3 Market Forecast (2024-2032)
7.4 Prostate Cancer
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2018-2023)
- 7.4.3 Market Forecast (2024-2032)
7.5 Cervical Cancer
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2018-2023)
- 7.5.3 Market Forecast (2024-2032)
7.6 Lung Cancer
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2018-2023)
- 7.6.3 Market Forecast (2024-2032)
7.7 Others
- 7.7.1 Historical and Current Market Trends (2018-2023)
- 7.7.2 Market Forecast (2024-2032)

8 Japan Radiotherapy Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
8.2 Cancer Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
8.3 Ambulatory and Radiotherapy Centers
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2018-2023)
- 8.3.3 Market Forecast (2024-2032)

9 Japan Radiotherapy Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2018-2023)
- 9.1.3 Market Breakup by Type
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End User
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2024-2032)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2018-2023)
- 9.2.3 Market Breakup by Type
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End User
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2024-2032)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2018-2023)
- 9.3.3 Market Breakup by Type
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End User
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2024-2032)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2018-2023)
- 9.4.3 Market Breakup by Type
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End User
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2024-2032)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2018-2023)
- 9.5.3 Market Breakup by Type
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End User
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2024-2032)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2018-2023)
- 9.6.3 Market Breakup by Type
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End User
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2024-2032)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2018-2023)
- 9.7.3 Market Breakup by Type
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End User
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2024-2032)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2018-2023)
- 9.8.3 Market Breakup by Type
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End User
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2024-2032)

10 Japan Radiotherapy Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Elekta K.K. (Elekta)
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Hitachi Ltd.
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Osaka Heavy Ion Therapy Center
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Sumitomo Heavy Industries Ltd.
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Toshiba Corporation
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

Please note that this is only a partial list of the key players, and the complete list is provided in the report.

12 Japan Radiotherapy Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis